青岛英派斯健康科技股份有限公司 股票交易异常波动公告

Group 1 - The company's stock experienced abnormal trading fluctuations, with a cumulative closing price increase of over 20% across three consecutive trading days (April 10, 11, and 14, 2025) [2] - The company conducted a self-examination and confirmed that there were no corrections or supplements needed for previously disclosed information [3] - The company is monitoring the impact of recent regulatory guidance from four government departments aimed at supporting the sports industry, which may affect its operations [3] Group 2 - The company's daily operations are normal, and there have been no significant changes in the external business environment [4] - The company is in the planning stage for potential external investments, with no finalized transaction details yet [4] - The company's controlling shareholders did not engage in any stock trading during the period of abnormal fluctuations [5] Group 3 - The board confirmed that there are no undisclosed significant matters that should be disclosed according to the Shenzhen Stock Exchange regulations [6] - The company does not anticipate needing to disclose performance forecasts and plans to release its 2024 annual report on April 28, 2025 [7] - The company emphasizes that all information should be verified through designated media outlets for accurate investment decisions [8]